The Connexion In all, 25 pharmaceutical generics will no longer be for sale after December 18, including versions of painkillers ibuprofen and tramadol, antihistamines desloratadine and ebastine, anti-depressant escitalopram, high blood pressure treatment ... and more »
Business Wire (press release) Global Market Report of Candesartan cilexetil (CAS 145040-37-5) aims at providing comprehensive data on Candesartan cilexetil globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Candesartan cilexetil market trends ... and more »
Medscape However, in CHARM-Added, candesartan decreased the combined end point (cardiovascular death and hospital readmission for CHF) even in the subpopulation that was already receiving an ACE inhibitor and beta-blocker. Meanwhile, the prevalence of ...
FiercePharma Manufacturing According to the FDA's most recent Enforcement Report, Sandoz initiated a Class III voluntary recall of 6,336 bottles of candesartan cilexetil after testing at 18 months found the drug contained more impurities than specification allows. In Class III ...
Pittsburgh Post Gazette Sandoz is recalling one lot of candesartan cilexetil 16 mg. tablets made by Mylan Laboratories in India because of a failed impurities test, according to the latest enforcement report from the Food and Drug Administration. Candesartan cilexetil is used ... and more »
7thSpace Interactive (press release) We therefore hypothesized that patients with hypertension treated with an angiotensin II receptor blocker ( candesartan ) would probably have an increased response to sodium-dependent glucose cotransporter inhibitor therapy (ipragliflozin) compared with ...
